United States Oral Contraceptive Market Report 2018

Publisher Name :
Date: 04-May-2018
No. of pages: 100
Inquire Before Buying

In this report, the United States Oral Contraceptive market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Oral Contraceptive in these regions, from 2013 to 2025 (forecast).

United States Oral Contraceptive market competition by top manufacturers/players, with Oral Contraceptive sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- Pfizer, Inc.

- Bayer AG

- Merck & Co., Inc.

- Janssen Global Services, LLC

- Mankind Pharma Ltd.

- Teva Pharmaceutical Industries Ltd

- Allergan, plc (Actavis)

- Piramal Enterprises Ltd.

- Beijing Zizhu Pharm

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Combination

- Progestin Only

- Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Male

- Female

United States Oral Contraceptive Market Report 2018

Table of Contents
United States Oral Contraceptive Market Report 2018
1 Oral Contraceptive Overview
1.1 Product Overview and Scope of Oral Contraceptive
1.2 Classification of Oral Contraceptive by Product Category
1.2.1 United States Oral Contraceptive Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Oral Contraceptive Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Combination
1.2.4 Progestin Only
1.2.5 Others
1.3 United States Oral Contraceptive Market by Application/End Users
1.3.1 United States Oral Contraceptive Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Male
1.3.3 Female
1.4 United States Oral Contraceptive Market by Region
1.4.1 United States Oral Contraceptive Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Oral Contraceptive Status and Prospect (2013-2025)
1.4.3 Southwest Oral Contraceptive Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Oral Contraceptive Status and Prospect (2013-2025)
1.4.5 New England Oral Contraceptive Status and Prospect (2013-2025)
1.4.6 The South Oral Contraceptive Status and Prospect (2013-2025)
1.4.7 The Midwest Oral Contraceptive Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Oral Contraceptive (2013-2025)
1.5.1 United States Oral Contraceptive Sales and Growth Rate (2013-2025)
1.5.2 United States Oral Contraceptive Revenue and Growth Rate (2013-2025)
2 United States Oral Contraceptive Market Competition by Players/Suppliers
2.1 United States Oral Contraceptive Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Oral Contraceptive Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Oral Contraceptive Average Price by Players/Suppliers (2013-2018)
2.4 United States Oral Contraceptive Market Competitive Situation and Trends
2.4.1 United States Oral Contraceptive Market Concentration Rate
2.4.2 United States Oral Contraceptive Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oral Contraceptive Manufacturing Base Distribution, Sales Area, Product Type
3 United States Oral Contraceptive Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Oral Contraceptive Sales and Market Share by Region (2013-2018)
3.2 United States Oral Contraceptive Revenue and Market Share by Region (2013-2018)
3.3 United States Oral Contraceptive Price by Region (2013-2018)
4 United States Oral Contraceptive Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Oral Contraceptive Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Oral Contraceptive Revenue and Market Share by Type (2013-2018)
4.3 United States Oral Contraceptive Price by Type (2013-2018)
4.4 United States Oral Contraceptive Sales Growth Rate by Type (2013-2018)
5 United States Oral Contraceptive Sales (Volume) by Application (2013-2018)
5.1 United States Oral Contraceptive Sales and Market Share by Application (2013-2018)
5.2 United States Oral Contraceptive Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Oral Contraceptive Players/Suppliers Profiles and Sales Data
6.1 Pfizer, Inc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oral Contraceptive Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer, Inc. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Bayer AG
6.2.2 Oral Contraceptive Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bayer AG Oral Contraceptive Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Merck & Co., Inc.
6.3.2 Oral Contraceptive Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Janssen Global Services, LLC
6.4.2 Oral Contraceptive Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Mankind Pharma Ltd.
6.5.2 Oral Contraceptive Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Teva Pharmaceutical Industries Ltd
6.6.2 Oral Contraceptive Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Allergan, plc (Actavis)
6.7.2 Oral Contraceptive Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Piramal Enterprises Ltd.
6.8.2 Oral Contraceptive Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Beijing Zizhu Pharm
6.9.2 Oral Contraceptive Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
7 Oral Contraceptive Manufacturing Cost Analysis
7.1 Oral Contraceptive Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Contraceptive
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Oral Contraceptive Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Contraceptive Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Oral Contraceptive Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Oral Contraceptive Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Oral Contraceptive Sales Volume Forecast by Type (2018-2025)
11.3 United States Oral Contraceptive Sales Volume Forecast by Application (2018-2025)
11.4 United States Oral Contraceptive Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Oral Contraceptive
Figure United States Oral Contraceptive Market Size (K Units) by Type (2013-2025)
Figure United States Oral Contraceptive Sales Volume Market Share by Type (Product Category) in 2017
Figure Combination Product Picture
Figure Progestin Only Product Picture
Figure Others Product Picture
Figure United States Oral Contraceptive Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Oral Contraceptive by Application in 2017
Figure Male Examples
Table Key Downstream Customer in Male
Figure Female Examples
Table Key Downstream Customer in Female
Figure United States Oral Contraceptive Market Size (Million USD) by Region (2013-2025)
Figure The West Oral Contraceptive Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Oral Contraceptive Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Oral Contraceptive Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Oral Contraceptive Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Oral Contraceptive Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Oral Contraceptive Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Oral Contraceptive Sales (K Units) and Growth Rate (2013-2025)
Figure United States Oral Contraceptive Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Oral Contraceptive Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Oral Contraceptive Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Oral Contraceptive Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Oral Contraceptive Sales Share by Players/Suppliers
Figure 2017 United States Oral Contraceptive Sales Share by Players/Suppliers
Figure United States Oral Contraceptive Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Oral Contraceptive Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Oral Contraceptive Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Oral Contraceptive Revenue Share by Players/Suppliers
Figure 2017 United States Oral Contraceptive Revenue Share by Players/Suppliers
Table United States Market Oral Contraceptive Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Oral Contraceptive Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Oral Contraceptive Market Share of Top 3 Players/Suppliers
Figure United States Oral Contraceptive Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oral Contraceptive Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oral Contraceptive Product Category
Table United States Oral Contraceptive Sales (K Units) by Region (2013-2018)
Table United States Oral Contraceptive Sales Share by Region (2013-2018)
Figure United States Oral Contraceptive Sales Share by Region (2013-2018)
Figure United States Oral Contraceptive Sales Market Share by Region in 2017
Table United States Oral Contraceptive Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Oral Contraceptive Revenue Share by Region (2013-2018)
Figure United States Oral Contraceptive Revenue Market Share by Region (2013-2018)
Figure United States Oral Contraceptive Revenue Market Share by Region in 2017
Table United States Oral Contraceptive Price (USD/Unit) by Region (2013-2018)
Table United States Oral Contraceptive Sales (K Units) by Type (2013-2018)
Table United States Oral Contraceptive Sales Share by Type (2013-2018)
Figure United States Oral Contraceptive Sales Share by Type (2013-2018)
Figure United States Oral Contraceptive Sales Market Share by Type in 2017
Table United States Oral Contraceptive Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Oral Contraceptive Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Oral Contraceptive by Type (2013-2018)
Figure Revenue Market Share of Oral Contraceptive by Type in 2017
Table United States Oral Contraceptive Price (USD/Unit) by Types (2013-2018)
Figure United States Oral Contraceptive Sales Growth Rate by Type (2013-2018)
Table United States Oral Contraceptive Sales (K Units) by Application (2013-2018)
Table United States Oral Contraceptive Sales Market Share by Application (2013-2018)
Figure United States Oral Contraceptive Sales Market Share by Application (2013-2018)
Figure United States Oral Contraceptive Sales Market Share by Application in 2017
Table United States Oral Contraceptive Sales Growth Rate by Application (2013-2018)
Figure United States Oral Contraceptive Sales Growth Rate by Application (2013-2018)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer, Inc. Oral Contraceptive Sales Growth Rate (2013-2018)
Figure Pfizer, Inc. Oral Contraceptive Sales Market Share in United States (2013-2018)
Figure Pfizer, Inc. Oral Contraceptive Revenue Market Share in United States (2013-2018)
Table Bayer AG Basic Information List
Table Bayer AG Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer AG Oral Contraceptive Sales Growth Rate (2013-2018)
Figure Bayer AG Oral Contraceptive Sales Market Share in United States (2013-2018)
Figure Bayer AG Oral Contraceptive Revenue Market Share in United States (2013-2018)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck & Co., Inc. Oral Contraceptive Sales Growth Rate (2013-2018)
Figure Merck & Co., Inc. Oral Contraceptive Sales Market Share in United States (2013-2018)
Figure Merck & Co., Inc. Oral Contraceptive Revenue Market Share in United States (2013-2018)
Table Janssen Global Services, LLC Basic Information List
Table Janssen Global Services, LLC Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Janssen Global Services, LLC Oral Contraceptive Sales Growth Rate (2013-2018)
Figure Janssen Global Services, LLC Oral Contraceptive Sales Market Share in United States (2013-2018)
Figure Janssen Global Services, LLC Oral Contraceptive Revenue Market Share in United States (2013-2018)
Table Mankind Pharma Ltd. Basic Information List
Table Mankind Pharma Ltd. Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mankind Pharma Ltd. Oral Contraceptive Sales Growth Rate (2013-2018)
Figure Mankind Pharma Ltd. Oral Contraceptive Sales Market Share in United States (2013-2018)
Figure Mankind Pharma Ltd. Oral Contraceptive Revenue Market Share in United States (2013-2018)
Table Teva Pharmaceutical Industries Ltd Basic Information List
Table Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales Growth Rate (2013-2018)
Figure Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales Market Share in United States (2013-2018)
Figure Teva Pharmaceutical Industries Ltd Oral Contraceptive Revenue Market Share in United States (2013-2018)
Table Allergan, plc (Actavis) Basic Information List
Table Allergan, plc (Actavis) Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Allergan, plc (Actavis) Oral Contraceptive Sales Growth Rate (2013-2018)
Figure Allergan, plc (Actavis) Oral Contraceptive Sales Market Share in United States (2013-2018)
Figure Allergan, plc (Actavis) Oral Contraceptive Revenue Market Share in United States (2013-2018)
Table Piramal Enterprises Ltd. Basic Information List
Table Piramal Enterprises Ltd. Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Piramal Enterprises Ltd. Oral Contraceptive Sales Growth Rate (2013-2018)
Figure Piramal Enterprises Ltd. Oral Contraceptive Sales Market Share in United States (2013-2018)
Figure Piramal Enterprises Ltd. Oral Contraceptive Revenue Market Share in United States (2013-2018)
Table Beijing Zizhu Pharm Basic Information List
Table Beijing Zizhu Pharm Oral Contraceptive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Beijing Zizhu Pharm Oral Contraceptive Sales Growth Rate (2013-2018)
Figure Beijing Zizhu Pharm Oral Contraceptive Sales Market Share in United States (2013-2018)
Figure Beijing Zizhu Pharm Oral Contraceptive Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Contraceptive
Figure Manufacturing Process Analysis of Oral Contraceptive
Figure Oral Contraceptive Industrial Chain Analysis
Table Raw Materials Sources of Oral Contraceptive Major Players/Suppliers in 2017
Table Major Buyers of Oral Contraceptive
Table Distributors/Traders List
Figure United States Oral Contraceptive Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Oral Contraceptive Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Oral Contraceptive Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Oral Contraceptive Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Oral Contraceptive Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Oral Contraceptive Sales Volume (K Units) Forecast by Type in 2025
Table United States Oral Contraceptive Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Oral Contraceptive Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Oral Contraceptive Sales Volume (K Units) Forecast by Application in 2025
Table United States Oral Contraceptive Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Oral Contraceptive Sales Volume Share Forecast by Region (2018-2025)
Figure United States Oral Contraceptive Sales Volume Share Forecast by Region (2018-2025)
Figure United States Oral Contraceptive Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Bacterial Vaginosis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 26-Oct-2018        Price: US 3480 Onwards        Pages: 116
    Bacterial vaginosis is an imbalance of "good" and "bad" bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching. Treatments for bacterial vaginosis include the use of probiotics and medication. Common drug classes include lincosamide antibiotics and nitroimidazole antibiotics. Scope of the Report: This report focuses on t......
  • Global Human Chorionic Gonadotropin Market Insights, Forecast to 2025
    Published: 26-Oct-2018        Price: US 3900 Onwards        Pages: 116
    Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta. hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men. hCG triggers ovulation in women and assists in increasing the sperm count in men. Global Human Chorionic Gonadotropin market size will increase to xx Million US$ by 2025, from xx Millio......
  • Global Human Chorionic Gonadotropin Market Growth 2018-2023
    Published: 24-Oct-2018        Price: US 3660 Onwards        Pages: 135
    Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta. hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men. hCG triggers ovulation in women and assists in increasing the sperm count in men. According to this study, over the next five years the Human Chorionic Gonadotropin market will ......
  • Global and United States Drugs for Vulvovaginal Candidiasis Market Research by Company, Type & Application 2013-2025
    Published: 21-Oct-2018        Price: US 2000 Onwards        Pages: 115
    Summary Market Segment as follows: By Type - Miconazole - Clotrimazole - Fluconazole - Econazole - Other By Application - Hospital & Clinic - Pharmacy By Company - Bayer - Perrigo - J & J - Pfizer - Bristol-Myers Squibb - Effik - Teva - Sanofi - Cisen Pharmaceutical - Kingyork Group The main contents of the repo......
  • Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 60
    Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Female Hypoactive Sexual Desire Disorder - Pipeline Review, H2 2018, provides an overview of the Female Hypoactive Sexual Desire Disorder (Women's Health) pipeline landscape. Hypoactive sexual desire disorder (HSDD) is an absence of sexual fantasies and desire for sexual activity. The predispos......
  • Women Infertility - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 202
    Women Infertility - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Pipeline Review, H2 2018, provides an overview of the Women Infertility (Women's Health) pipeline landscape. Infertility refers to failure to conceive over the course of one full year. Women infertility is caused due to damage of fallopian tubes, ovulation disorders (polycystic ovary syndrome) and......
  • Premenstrual Syndrome - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 35
    Premenstrual Syndrome - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Premenstrual Syndrome - Pipeline Review, H2 2018, provides an overview of the Premenstrual Syndrome (Women's Health) pipeline landscape. Premenstrual syndrome (PMS) is a collection of physical and emotional symptoms related to a woman's menstrual cycle. Premenstrual syndrome has a wide variety of symptoms, includ......
  • Global Oral Contraceptive Market Insights, Forecast to 2025
    Published: 15-Oct-2018        Price: US 3900 Onwards        Pages: 110
    In 2017, the global Oral Contraceptive market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Oral Contraceptive market based on company, product type, application and key regions. This report studies the global market size of Oral Contraceptive in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses......
  • Global Bacterial Vaginosis Drug Market Insights, Forecast to 2025
    Published: 04-Oct-2018        Price: US 3900 Onwards        Pages: 122
    This report studies the global market size of Bacterial Vaginosis Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bacterial Vaginosis Drug in these regions. This research report categorizes the global Bacterial Vaginosis Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, m......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs